Evidence map›Paper›PMID 34066520›Full record

ArticleInternational journal of molecular sciences2021

Identification of SYS1 as a Host Factor Required for Shiga Toxin-Mediated Cytotoxicity in Vero Cells.

Chisato Sakuma, Tsuyoshi Sekizuka, Makoto Kuroda, Kentaro Hanada, Toshiyuki Yamaji

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chisato SakumaDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Tsuyoshi SekizukaPathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Makoto KurodaPathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Kentaro HanadaDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Toshiyuki YamajiDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
National Institute of Infectious Diseases · JP

Funding

Japan Agency for Medical Research and Development JP19fm0208005j0102Japan Agency for Medical Research and Development JP19fm0208005j0103Japan Agency for Medical Research and Development JP20fk0108121j0201Japan Agency for Medical Research and Development JP20gm0910005j0006Japan Society for the Promotion of Science JP17K07357Ministry of Education, Culture, Sports, Science and Technology JP17H06417Mizutani Foundation for Glycoscience 160123
6 · The paper itself

Abstract

Shiga toxin (STx) or Vero toxin is a virulence factor produced by enterohemorrhagic

Indexed as

Amino Acid SequenceAnimalsCell DeathChlorocebus aethiopsCRISPR-Cas SystemsDrug Resistance, BacterialHumansMembrane ProteinsPolysaccharidesRNA-Binding ProteinsShiga Toxintrans-Golgi NetworkVero CellsMembrane ProteinsPolysaccharidesRNA-Binding ProteinsShiga ToxinCRISPR/CAS9genome-wide screeningglycosphingolipidShiga toxinSYS1Vero

Identifiers

PMID34066520
PMCPMC8124574
OpenAlexW3157415976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.